Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis

In patients with chronic noncancer pain, subcutaneous methylnaltrexone for opioid-induced constipation (OIC) was examined in a randomized controlled trial (RCT) followed by an open-label extension (OLE). This study examined the reproducibility of RCT findings by analyzing data from placebo-treated p...

Descripción completa

Detalles Bibliográficos
Autores principales: Viscusi, Eugene R., Barrett, Andrew C., Paterson, Craig, Forbes, William P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Chronic and Interventional Pain: Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684250/
https://www.ncbi.nlm.nih.gov/pubmed/26650429
http://dx.doi.org/10.1097/AAP.0000000000000341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684250/
https://www.ncbi.nlm.nih.gov/pubmed/26650429
http://dx.doi.org/10.1097/AAP.0000000000000341

Ejemplares similares